Clinical and Deep-Learning Based Quantitative Serial Chest CT Features of The COVID-19 Disease: Association with Clinical Subtypes and A Follow-Up Study
Abstract Background: To explore the clinical features and deep-learning (DL) based quantitative CT finding’s applications and evolution as well as the correlations in COVID-19.Methods: 273 chest CT scans (median interval, 6 days) from 75 COVID-19 RT-PCT positive patients (53 moderate and 22 severe) were included. Quantification parameters, such as CT value distribution, lesion (abnormal), GGO, consolidation rates, Hellinger distance and IOU, were automatically extracted from CT images by a combination of traditional image process algorithm and DL network. Clinical characteristics were also collected and analysed.Results: The hypertension and diabetes were more common in severity. The CRP, ESP, LDH and D-dimer were higher while LYM and LYM% lower in severity (P < 0.05). The DL network was detected the lesions to obtain quantitively CT indicators, with fast to process a chest CT images (average time, 2.2s) and high overlap with radiologist. The hellinger, abnormal, GGO, consolidation rates and HU values were higher and the IOU lower in severity than moderate patients (P < 0.05). The largest AUC was 0.943, using the cutoff value of 10.5% for abnormal rate. The CT score have postive correlations with CRP, D-dimer and ESR (P < 0.05). The increased levels of ESR and D-dimer were positively correlated with abnormal, consolidation and GGO rates (P < 0.05). Investigation for quantitative CT changes were performed in three periods: 1) 1-2 weeks, CT score and abnormal rate were increased. The GGO converted to consolidation in severity; 2) 2-5 weeks, CT scores stable trend, while abnormal and GGO rates had upward trend in severity; 3) > 5weeks, CT score and abnormal rate have decreased.Conclusions: There were three phases of two patterns’ evolutionary trends in quantitative CT findings with differences in two groups, and have correlations with laboratory markers, which helpful for evaluating severity and prognosis in COVID-19 patients.